Morning Market Spotlight: Under-the-Radar Movers & Breakouts Driving the Tape

August 28, 2025

DENVER, Colo., Aug 28, 2025 (247marketnews.com)- Here’s your crisp rundown of today’s stock market buzz, highlighting lesser-covered names alongside big movers like Pure Storage and Telomir Pharmaceuticals.

Pure Storage (NYSE:PSTG) stock is on fire, surging in pre-market after delivering strong fiscal Q2 results, reporting adjusted EPS of $0.43 on $861 million in revenue, beating consensus forecasts. UPGRADED OUTLOOK raised FY revenue guidance to $3.615B amid AI-driven demand and hyperscaler adoption, prompting a William Blair “Outperform” rating.

Telomir Pharmaceuticals (NASDAQ:TELO) broke new ground with potent in vitro data showing its lead candidate, Telomir‑1, can inhibit the previously “undruggable” enzyme UTX, a key regulator of DNA methylation linked to cancer, aging, and gene control. The drug also targets FBXL10/11 and JMJD3, expanding its potential as a first-in-class epigenetic reset therapy. Crucially, Telomir‑1 spared the broad acetyltransferase GCN5L2, underscoring a potentially cleaner safety profile.

LIXTE (NASDAQ:LIXT) will present at a landmark global conference focused on an unconventional but promising cancer strategy: activating oncogenic signaling to kill cancer cells. The peer-reviewed journal Trends in Cancer just published highlights from the meeting (Vol. 11, No. 7), reinforcing the momentum behind LIXTE’s lead asset, LB-100, a first-in-class PP2A inhibitor.

Data presented at the conference show LB-100 may drive tumor cells into lethal hyperactivation of growth pathways and enhance immune recognition via neoantigen formation. The company’s leadership role at the event, along with expanding clinical validation, positions LIXTE at the forefront of this emerging therapeutic paradigm.

Company Snapshots: Watchlist to Watch                      

CaliberCos (NASDAQ:CWD) reported $23.9 million in Q4 revenue, showing solid top-line strength. Traders looking for small-cap stability may see this as a refreshing outlier.

Continuing its turnover strategy, AquaBounty (NASDAQ:AQB) sold its Indiana aquaculture facility for $9.5 million, using proceeds to reduce debt. A leaner balance sheet could mean renewed focus on its flagship AquAdvantage salmon product. MarketWatch

Lion Group (NASDAQ:LGHL) is a crypto-leaning trading platform that’s quietly building its crypto reserves and recent buys include $5M–$9.6M in SUI and HYPE tokens.

With litigation behind it, Wheeler REIT (NASDAQ:WHLR) stands clear of legal risk. The real estate play, anchored in grocery-anchored retail, now appears clean to resume execution in a recovery setting.

IceCure Medical (NASDAQ:ICCM) secured FDA marketing authorization for its XSense Cryoablation System, opening U.S. commercialization. Strong demand could follow quickly as the system enters the market.

Continue monitoring Offerpad (NYSE:OPAD) ahead of its Q2 earnings release (expected August 4). The company just completed a $6 million direct offering and continues expanding asset-light services, especially its HomePro in-home seller program.

Healthcare-packaging specialist Sharps Technology (NASDAQ:STSS) has seen renewed interest following a $20 million capital raise, aimed at expanding manufacturing capacity. Buzz around its smart safety syringes is picking up, especially on micro-cap trading forums.

Tharimmune’s (NASDAQ: THAR) focus remains on its immunology pipeline, especially lead clinical candidate TH104, designed to address opioid-induced respiratory depression in military or chemical exposure settings. No new headlines today, but the fascinating pipeline remains notable.

Please go to https://247marketnews.com/lixte-biotechnology/ for further LIXT information and 247marketnews.com LIXT disclosure information.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (LIXT, PSTG, TELO, CWD, AQB, LGHL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.